Tosional better than longitudinal ultrasound in phaco

Article

Phacoemulsification procedures consume significantly less fluid using torsional compared with longituinal ultrasound in hard cataract cases, according to Khiun Tjia of the Netherlands.

Phacoemulsification procedures consume significantly less fluid using torsional compared with longituinal ultrasound in hard cataract cases, according to Khiun Tjia of the Netherlands.

At the Isala Clinics, Zwolle, Netherlands, hard cataracts were graded and yellow nuclei or denser were selected for the study. Cataracts were randomized to undergo either torsional (16) or longitudinal (16) ultrasound phaco procedures. Identical fluid dynamic parameters were set and the same tapered Kelman 45º tip was used. Torsional ultrasound was used in 100% continuous mode and longitudinal in pulse mode with 50% duty-cycle and 30 pulses/sec. All surgeries were performed by the same surgeon with a fast crack divide and conquer technique.

Torsional ultrasound used less fluid during the sculpt phase than longitudinal and significantly less than the longitudinal (p=0.0001) during irrigation/aspiration of cortical material. The quantities were similar during viscoelastice removal. Total fluid consumption for the two procedures was as follows: Torsional = 54.58 ml, longitudinal = 66.64 ml.

Tjia concluded that, since torsional ultrasound uses significantly less fluid it is a more efficient procedure than longitudinal ultrasound.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.